Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Med Chem ; 121: 517-529, 2016 Oct 04.
Article in English | MEDLINE | ID: mdl-27318976

ABSTRACT

5-Chloro-3-ethyl-N-(4-(piperidin-1-yl)phenethyl)-1H-indole-2-carboxamide (ORG27569, 1) is a prototypical allosteric modulator for the cannabinoid CB1 receptor. Based on this indole-2-carboxamide scaffold, we designed and synthesized novel CB1 allosteric modulators that possess photoactivatable functionalities, which include benzophenone, phenyl azide, aliphatic azide and phenyltrifluoromethyldiazrine. To assess their allosteric effects, the dissociation constant (KB) and allosteric binding cooperativity factor (α) were determined and compared to their parent compounds. Within this series, benzophenone-containing compounds 26 and 27, phenylazide-containing compound 28, and the aliphatic azide containing compound 36b showed allosteric binding parameters (KB and α) comparable to their parent compound 1, 7, 8, and 9, respectively. We further assessed these modulators for their impact on G-protein coupling activity. Interestingly, these compounds exhibited negative allosteric modulator properties in a manner similar to their parent compounds, which antagonize agonist-induced G-protein coupling. These novel CB1 allosteric modulators, possessing photoactivatable functionalities, provide valuable tools for future photo-affinity labeling and mapping the CB1 allosteric binding site(s).


Subject(s)
Indoles/chemical synthesis , Indoles/pharmacology , Light , Receptor, Cannabinoid, CB1/metabolism , Allosteric Regulation/drug effects , Allosteric Regulation/radiation effects , Chemistry Techniques, Synthetic , HEK293 Cells , Humans , Indoles/chemistry , Receptor, Cannabinoid, CB1/chemistry
2.
Molecules ; 20(12): 22272-85, 2015 Dec 11.
Article in English | MEDLINE | ID: mdl-26690407

ABSTRACT

Bedaquiline is the first FDA-approved new chemical entity to fight multidrug-resistant tuberculosis in the last forty years. Our group replaced the quinoline ring with a naphthalene ring, leading to a new type of triarylbutanol skeleton. An asymmetric synthetic route was established for our bedaquiline analogues, and the goal of assigning their absolute configurations was achieved by comparison of experimental and calculated electronic circular dichroism spectra, and was confirmed by the combined use of circular dichroism and NMR spectroscopy.


Subject(s)
Antitubercular Agents/chemical synthesis , Diarylquinolines/chemistry , Naphthalenes/chemistry , Quinolines/chemistry , Circular Dichroism , Drug Design , Magnetic Resonance Spectroscopy , Models, Molecular , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL
...